Authors


Bonnie An Henderson, MD

Latest:

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

The EnVision Summit, co-founded by Bonnie An Henderson, MD, is a unique family-oriented, multispecialty ophthalmology CME conference, along with a newly introduced optometry track. Henderson sits down with Ophthalmology Times to talk about the 2025 conference that will take place February 14 to 17 at the Caribe Hilton San Juan, in Puerto Rico.



Sydney M Crago

Latest:

Ask the Experts: What problem in ophthalmology do you wish there was a solution for?

This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.


S.K. Steven Houston III, MD, FASRS

Latest:

Welcome to the metaverse: Technology allows ophthalmologists to mingle with colleagues worldwide

Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.


Nancy Holekamp, MD

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Marco Mura, MD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Karl Stonecipher, MD

Latest:

Final Pearls on Managing Dry Eye Patients With Comorbidities

Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.


Mark T. Dunbar, OD, FAAO

Latest:

ACHIEVING IMPROVED OUTCOMES THROUGH PARTNERSHIPS BETWEEN OPTOMETRISTS AND RETINA SPECIALISTS

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.


Samir N. Patel, MD

Latest:

Focusing on postinjection endophthalmitis

Systemic immunosuppression may prevent devastating complication in patients.



Victor H. Gonzalez, MD

Latest:

Seize underutilized opportunity to treat glaucoma during vitrectomy

Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.


Marta Ibarz Barberá, MD

Latest:

Benefits of topography-guided treatments for irregular corneas

Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.


Frank Joseph Goes, MD

Latest:

Inherited retinal diseases meet their therapeutic match

The retina is a key proving ground for long-held theories of genetics.


Marina Roizenblatt, MD, PhD

Latest:

The evolving role of vitreosurgical simulators in surgical training

Need to eliminate errors results in optimization of training of novice surgeons.


Carl D. Regillo, MD, FACS, FASRS

Latest:

Considerations for the Future of Biosimilars in the Treatment of Retinal Disorders

Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.


Dilraj S. Grewal, MD

Latest:

Weighing treatments for chronic postop cystoid macular edema

Prompt and adequate action is a key to facilitating the best recovery in patients.


Kassi Jackson

Latest:

FDA approves RYZUMVI (Phentolamine Ophthalmic Solution) for the treatment of pharmacologically-induced mydriasis

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.


Gary W. Jerkins, MD

Latest:

Increasing your practice’s reach, relevance, and revenue with clinical trials

Working as an investigator can prove to be a positive experience for physicians


Kamran M. Riaz, MD

Latest:

Mixing and Matching Monofocal Plus IOLs with Other Advanced Technology IOLs

Kamran Riaz, MD, reviews a cataract surgery case where the patient was fitted with different IOLs in each eye.


Rahul T. Pandit, MD

Latest:

The eyes offer conjunctival clue to COVID-19

A patient's vision loss leads to another diagnosis


Livia George, BS

Latest:

Unlocking health mysteries

Researchers find a strong link between Alzheimer's disease and retinal thinning


Neda Shamie, MD

Latest:

CIME 2024: Neda Shamie, MD, recaps a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion

The 18th annual Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and Arjan Hura, MD, with the aim of discussing the latest advancements in eye care.


Douglas Rhee, MD

Latest:

From waste to wonder: Transformational advances in scleral allograft technology

Unlocking the potential of donor scleral tissue: Innovations and future applications.



Dilsher S. Dhoot, MD

Latest:

Patient case 2: DME Patient Treated with Ranibizumab Biosimilar

Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.


A. Paul Chous, MA, OD, FAAO

Latest:

EyeCon 2024: Key takeaways for enhanced patient care from Day 1

Optometry cochairs Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, highlight the conference’s focus on collaboration, featuring topics like red flags for patient care, thyroid eye disease, and diabetes management.


James G. Chelnis, MD

Latest:

Driving practice growth: Expand on link between dry eye, aesthetics

One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.


Dagny Zhu, MD

Latest:

Ocular surface health and IOL choices

Enhanced monofocal technology may benefit patients with cataracts and dry eye.



Howard D. Pomeranz, MD, PhD

Latest:

Protection of eyes during prone positioning must be routinely monitored in ICU

Treatment of patients with COVID-19 should include ophthalmic considerations.

© 2024 MJH Life Sciences

All rights reserved.